Commissioned by Intercept Pharma UK & Ireland Ltd

Intercept logo

This webinar has been commissioned by Intercept Pharma UK & Ireland Ltd and organised in partnership with Guidelines in Practice. Intercept Pharma UK & Ireland Ltd has reviewed the scope of the webinar, worked with MGP to choose and commission speakers, and approved all materials related to the webinar in relation to the ABPI Code but has otherwise had no editorial control. The speakers have not received any payment for presenting the webinar. The views and opinions of the speakers are not necessarily those of Intercept Pharma UK & Ireland Ltd, Guidelines in Practice, its publisher, advisers, or advertisers 

Intercept webinar banner

Tuesday 3 July, 12.30–13.30

This Guidelines in Practice webinar will cover those elements of the guideline that are most pertinent to demonstrating quality of care in primary biliary cholangitis (PBC). This will be relevant for any healthcare professional involved in the management of patients with PBC in the UK and will:

Earn 1 cpd

  • provide an overview of primary biliary cholangitis including diagnosis and risk stratification
  • cover treatment and medical management
  • review management of symptoms
  • include patient case studies
  • summarise the audit standards
  • provide guidance-related CPD.

This webinar has been developed in collaboration with 

Uk pbc logo vector

 

 

 

 

Register and submit your questions to the speakers:

Dave jones

Professor David Jones

Professor of Liver Immunology
Newcastle University
Honorary Consultant Hepatologist
Newcastle upon Tyne Hospitals NHS Foundation Trust

 

 

Gideon hirschfield

Professor Gideon Hirschfield

Professor of Autoimmune Liver Disease
University of Birmingham
Honorary Consultant Transplant Hepatologist
University Hospitals Birmingham NHS Foundation Trust 

 

 

Click here to register for free

UK-NP-PB-0290

Date of preparation: May 2018